The Patent Finder

GIP/GLP1 Agonist Compositions

Eli Lilly and Company

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 62/688,632, filed Jun 22, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,357,820GIP/GLP1 Agonist Compositions
In force
 · High confidence
UsedRemaining
Eli Lilly and CompanyIn forceHigh confidence
US 11,918,623GIP/GLP1 Agonist Compositions
In force
 · High confidence
Eli Lilly and CompanyIn forceHigh confidence
US 12,453,755GIP/GLP1 Agonist Compositions
In force
 · High confidence
Eli Lilly and CompanyIn forceHigh confidence
US 12,453,756GIP/GLP1 Agonist Compositions
In force
 · High confidence
Eli Lilly and CompanyIn forceHigh confidence
US 12,629,404GIP/GLP1 Agonist Compositions
In force
 · High confidence
Eli Lilly and CompanyIn forceHigh confidence
Application 19/276,978GIP/GLP1 Agonist Compositions
Pending
Not granted
Eli Lilly and CompanyPendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Eli Lilly and Company.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited